semaglutide diarrhea class action in michigan A South African court has ordered pharmacy group iDexis to stop selling semaglutide-based medicines. The ruling follows a legal challenge by Novo Nordisk, maker of Ozempic and Wegovy. Novo alleged the company Opinion | GLP-1 Experimentation Is

In these 68-week trials, semaglutide was associated with significantly greater weight loss compared to placebo

How much do GLP-1 drugs cost without insurance

Always consult with your healthcare professional before starting any new medication, even over-the-counter options, to ensure its the right fit for your situation

As you reach your maintenance dose and usage becomes predictable, you can order more efficiently

This regulatory action follows a similar timeline for the active ingredient tirzepatide, used in Mounjaro and Zepbound, which were also affected by shortages until the FDA deemed them resolved in December 2024